80_FR_56657 80 FR 56476 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

80 FR 56476 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 181 (September 18, 2015)

Page Range56476-56476
FR Document2015-23443

Federal Register, Volume 80 Issue 181 (Friday, September 18, 2015)
[Federal Register Volume 80, Number 181 (Friday, September 18, 2015)]
[Notices]
[Page 56476]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-23443]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by live 
webcast.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of meeting: Open Meeting.
    Date: November 13, 2015.
    Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and reduced disease burden. Prior to the meeting, an agenda will be 
posted to the MDCC meeting registration Web site: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.
    Webcast Live: For those not able to attend in person, this 
meeting will be webcast at: http://videocast.nih.gov/.
    Place: Neuroscience Center, Conference Room C/D, 6001 Executive 
Boulevard, Rockville, Maryland 20852.
    Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2203, Rockville, MD 20852, (301) 496-5739, 
glen.nuckolls@ninds.nih.gov.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Attendance is limited to seating space available. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
inform the Contact Person listed above in advance of the meeting. 
All visitors must go through a security check at the meeting site to 
receive a visitor's badge. A valid, government issued photo ID must 
be presented before a visitor's badge can be issued. Further 
information can be found at the registration Web site: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

     Dated: September 14, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-23443 Filed 9-17-15; 8:45 am]
BILLING CODE 4140-01-P



                                              56476                       Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices

                                                Agenda: To review and evaluate grant                  Coordinating Committee, National Institute            High Throughput Prioritization and
                                              applications.                                           of Neurological Disorders and Stroke, NIH,            Decision Making.’’ Attendees at the in-
                                                Place: Crowne Plaza Washington National               6001 Executive Boulevard, NSC 2203,                   person workshop and four webinar
                                              Airport, 1489 Jefferson Davis Hwy, Arlington,           Rockville, MD 20852, (301) 496–5739,
                                              VA 22202.
                                                                                                                                                            presentations leading up to the
                                                                                                      glen.nuckolls@ninds.nih.gov.
                                                Contact Person: Ryan G Morris, Ph.D.,                                                                       workshop will discuss the state of the
                                                                                                         Any member of the public interested in
                                              Scientific Review Officer, Center for                   presenting oral comments to the committee
                                                                                                                                                            science and best practices for using in
                                              Scientific Review, National Institutes of               may notify the Contact Person listed on this          vitro to in vivo extrapolation (IVIVE) in
                                              Health, 6701 Rockledge Drive, Room 4205,                notice at least 10 days in advance of the             a tiered risk decision context.
                                              MSC 7814, Bethesda, MD 20892, 301–435–                  meeting. Interested individuals and                   DATES: Webinars: October 7, 2015, at
                                              1501, morrisr@csr.nih.gov.                              representatives of organizations may submit           11:00 a.m. Eastern Daylight Time (EDT);
                                              (Catalogue of Federal Domestic Assistance               a letter of intent, a brief description of the        and November 4, 2015; December 2,
                                              Program Nos. 93.306, Comparative Medicine;              organization represented, and a short
                                              93.333, Clinical Research, 93.306, 93.333,                                                                    2015; and January 6, 2016; at 11:00 a.m.
                                                                                                      description of the oral presentation. Only one
                                              93.337, 93.393–93.396, 93.837–93.844,                                                                         Eastern Standard Time (EST).
                                                                                                      representative of an organization may be
                                              93.846–93.878, 93.892, 93.893, National                 allowed to present oral comments and if
                                                                                                                                                               Webinar Registration: Deadline is two
                                              Institutes of Health, HHS)                              accepted by the committee, presentations              business days prior to each webinar.
                                                Dated: September 14, 2015.                            may be limited to five minutes. Both printed             Workshop: February 17–18, 2016,
                                                                                                      and electronic copies are requested for the           from 9:00 a.m. to approximately 5:00
                                              Melanie J. Gray,
                                                                                                      record. In addition, any interested person            p.m. (EST).
                                              Program Analyst, Office of Federal Advisory                                                                      Workshop Registration: Deadline is
                                                                                                      may file written comments with the
                                              Committee Policy.
                                                                                                      committee by forwarding their statement to            February 5, 2016 at 5:00 p.m. (EST).
                                              [FR Doc. 2015–23387 Filed 9–17–15; 8:45 am]             the Contact Person listed on this notice. The         ADDRESSES:
                                              BILLING CODE 4140–01–P                                  statement should include the name, address,              Workshop Location: U.S.
                                                                                                      telephone number and when applicable, the
                                                                                                      business or professional affiliation of the
                                                                                                                                                            Environmental Protection Agency, 109
                                              DEPARTMENT OF HEALTH AND                                interested person.                                    T.W. Alexander Dr., Durham, NC,
                                              HUMAN SERVICES                                             Attendance is limited to seating space             27709.
                                                                                                      available. Individuals who plan to attend and            Web page: The preliminary agenda,
                                              National Institutes of Health                           need special assistance, such as sign                 registration, and other meeting materials
                                                                                                      language interpretation or other reasonable           will be available at http://
                                              National Institute of Neurological                      accommodations, should inform the Contact             ntp.niehs.nih.gov/go/ivive-wksp-2016.
                                              Disorders and Stroke; Notice of                         Person listed above in advance of the                 FOR FURTHER INFORMATION CONTACT: Dr.
                                              Meeting                                                 meeting. All visitors must go through a
                                                                                                      security check at the meeting site to receive
                                                                                                                                                            Warren S. Casey, Director, NICEATM;
                                                Pursuant to section 10(a) of the                      a visitor’s badge. A valid, government issued         email: warren.casey@nih.gov; telephone:
                                              Federal Advisory Committee Act, as                      photo ID must be presented before a visitor’s         (919) 316–4729.
                                              amended (5 U.S.C. App.), notice is                      badge can be issued. Further information can          SUPPLEMENTARY INFORMATION:
                                              hereby given of a meeting of the                        be found at the registration Web site:                   Background: Data from high
                                                                                                      https://meetings.ninds.nih.gov/meetings/              throughput in vitro tests are being
                                              Muscular Dystrophy Coordinating
                                                                                                      MDCC13Nov2015/.                                       generated for many chemicals of
                                              Committee (MDCC).
                                                The meeting will be open to the                       (Catalogue of Federal Domestic Assistance             environmental and commercial interest,
                                                                                                      Program Nos. 93.853, Clinical Research                with the expectation that in vitro assay
                                              public and accessible by live webcast.                  Related to Neurological Disorders; 93.854,            data could ultimately be used to predict
                                                Name of Committee: Muscular Dystrophy                 Biological Basis Research in the
                                              Coordinating Committee.                                 Neurosciences, National Institutes of Health,
                                                                                                                                                            adverse effects of chemical exposures in
                                                Type of meeting: Open Meeting.                        HHS)                                                  vivo. Translating values obtained from
                                                Date: November 13, 2015.                                                                                    in vitro assays into estimates of in vivo
                                                Time: 8:30 a.m. to 4:30 p.m. *Eastern                   Dated: September 14, 2015.                          outcomes is a complex process
                                              Time*—Approximate end time.                             Carolyn Baum,                                         involving the use of mathematical
                                                Agenda: The purpose of this meeting is to             Program Analyst, Office of Federal Advisory           modeling and increasingly complex test
                                              bring together committee members,                       Committee Policy.                                     systems. The series of four webinars and
                                              representing government agencies, patient               [FR Doc. 2015–23443 Filed 9–17–15; 8:45 am]
                                              advocacy groups, other voluntary health
                                                                                                                                                            in-person workshop aim to address the
                                              organizations, and patients and their families          BILLING CODE 4140–01–P                                capabilities and limitations of IVIVE
                                              to update one another on progress relevant to                                                                 within the context of risk decision-
                                              the Action Plan for the Muscular Dystrophies                                                                  making.
                                              and to coordinate activities and discuss gaps           DEPARTMENT OF HEALTH AND                                 The webinar series will present the
                                              and opportunities leading to better                     HUMAN SERVICES                                        current science, and the in-person
                                              understanding of the muscular dystrophies,                                                                    workshop will facilitate discussions that
                                              advances in treatments, and reduced disease             National Institutes of Health                         follow-up and build on information
                                              burden. Prior to the meeting, an agenda will
                                              be posted to the MDCC meeting registration              In Vitro to In Vivo Extrapolation for                 presented in the webinars. During the
                                              Web site: https://meetings.ninds.nih.gov/               High Throughput Prioritization and                    workshop, participants will (1) review
                                              meetings/MDCC13Nov2015/.                                Decision Making; Notice of Webinars                   the state of the science to form
                                                Registration: To register, please go to:              and Public Workshop; Registration                     recommendations on best practices for
                                              https://meetings.ninds.nih.gov/meetings/
                                                                                                      Information                                           using IVIVE in chemical screening and
                                              MDCC13Nov2015/.                                                                                               risk-based decision making, (2) identify
tkelley on DSK3SPTVN1PROD with NOTICES




                                                Webcast Live: For those not able to attend            SUMMARY:    The National Toxicology                   areas that require additional data and/or
                                              in person, this meeting will be webcast at:             Program (NTP) Interagency Center for                  research, and (3) highlight examples of
                                              http://videocast.nih.gov/.
                                                Place: Neuroscience Center, Conference
                                                                                                      the Evaluation of Alternative                         how best to apply IVIVE in a tiered risk
                                              Room C/D, 6001 Executive Boulevard,                     Toxicological Methods (NICEATM) and                   decision-making strategy.
                                              Rockville, Maryland 20852.                              the U.S. Environmental Protection                        Preliminary Agenda and Other
                                                Contact Person: Glen H. Nuckolls, Ph.D.,              Agency (EPA) announce the workshop,                   Meeting Information: A preliminary
                                              Executive Secretary, Muscular Dystrophy                 ‘‘In Vitro to In Vivo Extrapolation for               agenda and additional information will


                                         VerDate Sep<11>2014   19:33 Sep 17, 2015   Jkt 235001   PO 00000   Frm 00040   Fmt 4703   Sfmt 4703   E:\FR\FM\18SEN1.SGM   18SEN1



Document Created: 2015-12-15 09:27:33
Document Modified: 2015-12-15 09:27:33
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 13, 2015.
FR Citation80 FR 56476 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR